- Home
- LFCR vs NEWT Comparison
LFCR vs NEWT Comparison
Compare LFCR & NEWT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFCR
- NEWT
- Stock Information
- Founded
- LFCR 1986
- NEWT 1998
- Country
- LFCR United States
- NEWT United States
- Employees
- LFCR N/A
- NEWT N/A
- Industry
- LFCR Biotechnology: Pharmaceutical Preparations
- NEWT Major Banks
- Sector
- LFCR Health Care
- NEWT Finance
- Exchange
- LFCR Nasdaq
- NEWT Nasdaq
- Market Cap
- LFCR 308.8M
- NEWT 294.8M
- IPO Year
- LFCR N/A
- NEWT N/A
- Fundamental
- Price
- LFCR $7.61
- NEWT $12.37
- Analyst Decision
- LFCR Buy
- NEWT Hold
- Analyst Count
- LFCR 4
- NEWT 4
- Target Price
- LFCR $8.00
- NEWT $13.00
- AVG Volume (30 Days)
- LFCR 108.3K
- NEWT 188.9K
- Earning Date
- LFCR 08-07-2025
- NEWT 07-28-2025
- Dividend Yield
- LFCR N/A
- NEWT 6.14%
- EPS Growth
- LFCR N/A
- NEWT 21.23
- EPS
- LFCR N/A
- NEWT 2.01
- Revenue
- LFCR $128,867,000.00
- NEWT $364,004,000.00
- Revenue This Year
- LFCR $4.78
- NEWT N/A
- Revenue Next Year
- LFCR $12.02
- NEWT $12.73
- P/E Ratio
- LFCR N/A
- NEWT $6.15
- Revenue Growth
- LFCR 0.47
- NEWT 20.91
- 52 Week Low
- LFCR $3.68
- NEWT $9.12
- 52 Week High
- LFCR $8.85
- NEWT $15.49
- Technical
- Relative Strength Index (RSI)
- LFCR 53.94
- NEWT 61.20
- Support Level
- LFCR $7.33
- NEWT $12.16
- Resistance Level
- LFCR $7.73
- NEWT $12.48
- Average True Range (ATR)
- LFCR 0.30
- NEWT 0.27
- MACD
- LFCR 0.03
- NEWT 0.02
- Stochastic Oscillator
- LFCR 65.33
- NEWT 73.00
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.
About NEWT NewtekOne Inc.
NewtekOne Inc is a financial holding company engaged in providing financial solutions to its Client Base. It is an internally managed non-diversified closed-end management investment company. It has four reportable segments Banking, Alternative Lending, Technology, NSBF, and Payments.